(Q37159513)

18 August 2017

1 reference

title

Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients (English)

1 reference

Adaptive radiation therapy

18 August 2017

main subject

0 references

1 reference

James W Clarke

1

1 reference

18 August 2017

Eric L Chang

2

1 reference

18 August 2017

Victor A Levin

3

1 reference

18 August 2017

Nina A Mayr

4

1 reference

18 August 2017

Eugene Hong

5

1 reference

18 August 2017

Robert Cavaliere

6

1 reference

18 August 2017

Simon S Lo

7

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Anticancer Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

733-741

1 reference

Increasing annual incidence of primary malignant brain tumors in the elderly.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Management of patients aged over 60 years with supratentorial glioma: lessons from an audit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Debulking or biopsy of malignant glioma in elderly people - a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A prospective study on glioblastoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hypofractionation in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Short course radiotherapy is an appropriate option for most malignant glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Large dose fraction radiotherapy in the treatment of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.5.733

21 January 2018

Identifiers

DOI

10.1586/14737140.8.5.733

1 reference

18 August 2017

1 reference